Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ranbaxy Laboratories Ltd.

Division of Sun Pharmaceutical Industries Ltd.
www.ranbaxy.com

Latest From Perrigo Israel Pharmaceuticals Ltd.

ANDA Litigation Soars In 2014-2015; Patent Office Petitions Also Jump

Purdue's OxyContin and Amarin's Vascepa lead the list of targets as an increasing number of generic firms take up litigation.

BioPharmaceutical United States

FDA’s Top Agenda Maker: Commissioner, Congress – Or The Courts?

Agency chief counsel says continued priority-setting through lawsuits eventually may affect public health, while professor says FDA discretion not to act is at stake in some cases.

Consumer BioPharmaceutical

FDA’s Top Agenda Maker: Commissioner, Congress – Or The Courts?

Agency chief counsel says continued priority-setting through lawsuits eventually may affect public health, while professor says FDA discretion not to act is at stake in some cases.

BioPharmaceutical United States

Bioequivalence Standards For Testosterone Gel At Issue In Perrigo v. FDA Suit

Perrigo’s 505(b)(2) product lacks a therapeutic equivalence rating more than a year after approval; firm says FDA found it bioequivalent to AbbVie’s AndroGel.

BioPharmaceutical United States
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register